Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Climb Bio (CLYM) Shares Issued (2021 - 2026)

Climb Bio filings provide 4 years of Shares Issued readings, the most recent being $5000.0 for Q1 2026.

  • Quarterly Shares Issued changed N/A to $5000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Mar 2026, down 100.0% year-over-year, with the annual reading at $11.0 million for FY2024, 1205.47% up from the prior year.
  • Shares Issued hit $5000.0 in Q1 2026 for Climb Bio, down from $41000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $119.7 million in Q2 2024 and bottomed at $1000.0 in Q1 2023.
  • Average Shares Issued over 3 years is $13.7 million, with a median of $41000.0 recorded in 2024.
  • Peak annual rise in Shares Issued hit 498845.83% in 2024, while the deepest fall reached 85.76% in 2024.
  • Climb Bio's Shares Issued stood at $288000.0 in 2023, then plummeted by 85.76% to $41000.0 in 2024, then tumbled by 87.8% to $5000.0 in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Shares Issued are $5000.0 (Q1 2026), $41000.0 (Q4 2024), and $2.3 million (Q3 2024).